Zai Lab Ltd
ZLAB32.650USD
-0.350-1.06%
Fechamento 09/19, 16:00（ET）Cotações atrasadas em 15 min
3.59BValor de mercado
PerdaP/L TTM
Mais detalhes de Zai Lab Ltd Empresa
Zai Lab Ltd is a holding company primarily engaged in biopharmaceuticals. The Company is committed to addressing the unmet medical needs in the fields of tumors, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The Company has a series of patented drug candidates from the discovery stage to the late clinical project. These include ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others.
Informações da empresa
Código da empresaZLAB
Nome da EmpresaZai Lab Ltd
Data de listagemSep 28, 2020
CEODr. Ying (Samantha) Du, Ph.D.
Número de funcionários1869
Tipo de títulosDepository Receipt
Fim do ano fiscalSep 28
EndereçoBuilding B, 899 Halei Road, Pudong
CidadeSHANGHAI
Bolsa de valoresNASDAQ Global Market Consolidated
PaísChina
Código postal201203
Telefone862161632588
Sitehttps://www.zailaboratory.com/
Código da empresaZLAB
Data de listagemSep 28, 2020
CEODr. Ying (Samantha) Du, Ph.D.
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. John David Diekman, Ph.D.
Dr. John David Diekman, Ph.D.
Lead Independent Director
Lead Independent Director
99.77K
+12.18%
Mr. Joshua L. Smiley
Mr. Joshua L. Smiley
President, Chief Operating Officer
President, Chief Operating Officer
86.60K
+13.05%
Mr. William David (Bill) Lis
Mr. William David (Bill) Lis
Independent Director
Independent Director
35.11K
-7.83%
Dr. Yajing Chen, Ph.D.
Dr. Yajing Chen, Ph.D.
Chief Financial Officer
Chief Financial Officer
16.72K
-20.40%
Mr. Leon Oliver (Lonnie) Moulder, Jr.
Mr. Leon Oliver (Lonnie) Moulder, Jr.
Independent Director
Independent Director
--
--
Mr. Michel Pericles Vounatsos
Mr. Michel Pericles Vounatsos
Independent Director
Independent Director
--
--
Dr. Richard B. Gaynor, M.D.
Dr. Richard B. Gaynor, M.D.
Independent Director
Independent Director
--
--
Ms. Leung (Nisa Bernice) Wing-Yu
Ms. Leung (Nisa Bernice) Wing-Yu
Independent Director
Independent Director
--
--
Mr. Peter Karl Wirth, J.D.
Mr. Peter Karl Wirth, J.D.
Independent Director
Independent Director
--
--
Ms. Christine Chiou
Ms. Christine Chiou
Senior Vice President, Head - Investor Relations
Senior Vice President, Head - Investor Relations
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. John David Diekman, Ph.D.
Dr. John David Diekman, Ph.D.
Lead Independent Director
Lead Independent Director
99.77K
+12.18%
Mr. Joshua L. Smiley
Mr. Joshua L. Smiley
President, Chief Operating Officer
President, Chief Operating Officer
86.60K
+13.05%
Mr. William David (Bill) Lis
Mr. William David (Bill) Lis
Independent Director
Independent Director
35.11K
-7.83%
Dr. Yajing Chen, Ph.D.
Dr. Yajing Chen, Ph.D.
Chief Financial Officer
Chief Financial Officer
16.72K
-20.40%
Mr. Leon Oliver (Lonnie) Moulder, Jr.
Mr. Leon Oliver (Lonnie) Moulder, Jr.
Independent Director
Independent Director
--
--
Mr. Michel Pericles Vounatsos
Mr. Michel Pericles Vounatsos
Independent Director
Independent Director
--
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
Por EmpresaUSD
Nome
Receita
Proporção
ZEJULA
49.53M
46.88%
VYVGART
18.11M
17.14%
NUZYRA
15.12M
14.31%
Optune
11.36M
10.76%
QINLOCK
8.51M
8.05%
Outro
3.03M
2.86%
Sem dados
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
ZEJULA
49.53M
46.88%
VYVGART
18.11M
17.14%
NUZYRA
15.12M
14.31%
Optune
11.36M
10.76%
QINLOCK
8.51M
8.05%
Outro
3.03M
2.86%
Distribuição de ações
Atualizado em: sáb, 16 de ago
Atualizado em: sáb, 16 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Capital World Investors
5.40%
RTW Investments L.P.
4.95%
Fidelity Management & Research Company LLC
4.37%
ClearBridge Investments, LLC
3.59%
Janus Henderson Investors
1.97%
Outro
79.72%
Investidores
Investidores
Proporção
Capital World Investors
5.40%
RTW Investments L.P.
4.95%
Fidelity Management & Research Company LLC
4.37%
ClearBridge Investments, LLC
3.59%
Janus Henderson Investors
1.97%
Outro
79.72%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
16.87%
Investment Advisor
16.18%
Hedge Fund
5.50%
Individual Investor
1.74%
Private Equity
1.38%
Venture Capital
1.13%
Research Firm
0.89%
Pension Fund
0.44%
Sovereign Wealth Fund
0.18%
Outro
55.69%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
394
60.58M
54.15%
-11.96M
2025Q1
453
59.51M
53.68%
-14.18M
2024Q4
446
60.80M
55.47%
-4.29M
2024Q3
439
51.45M
51.99%
-10.14M
2024Q2
454
47.04M
47.66%
-14.67M
2024Q1
465
46.22M
46.47%
-13.77M
2023Q4
497
46.31M
46.92%
-16.57M
2023Q3
537
44.27M
45.68%
-20.42M
2023Q2
568
47.21M
48.74%
-23.76M
2023Q1
572
60.29M
61.61%
-11.82M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Capital World Investors
6.01M
5.41%
-425.00K
-6.61%
Mar 31, 2025
RTW Investments L.P.
3.14M
2.82%
+627.56K
+25.01%
Mar 31, 2025
Fidelity Management & Research Company LLC
4.68M
4.21%
+945.91K
+25.33%
Mar 31, 2025
ClearBridge Investments, LLC
3.28M
2.95%
+1.42M
+76.05%
Mar 31, 2025
Janus Henderson Investors
3.81M
3.43%
-2.75M
-41.94%
Mar 31, 2025
Baron Capital Management, Inc.
1.83M
1.65%
-79.59K
-4.17%
Mar 31, 2025
Segantii Capital Management Limited
1.56M
1.4%
-131.64K
-7.80%
Mar 31, 2024
Wellington Management Company, LLP
3.65M
3.28%
-3.01M
-45.22%
Mar 31, 2025
Fidelity Institutional Asset Management
1.70M
1.53%
-43.29K
-2.49%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de set
Atualizado em: sáb, 6 de set
Nome
Proporção
SPDR Portfolio MSCI Global Stock Market ETF
0%
Innovator IBD 50 Fund ETF
0%
SPDR MSCI Emerging Markets Fossil Fuel Reserves Free ETF
0%
ProShares Ultra Nasdaq Biotechnology
0%
National Security Emerging Markets Index ETF
0%
Invesco Nasdaq Biotechnology ETF
0%
Xtrackers Emg Mkt Carbon Reduction and Cl Imp ETF
0%
DFA Dimensional Emerging Core Equity Market ETF
0%
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
0%
WisdomTree Emerging Markets Efficient Core Fund
0%
SPDR Portfolio MSCI Global Stock Market ETF
Proporção0%
Innovator IBD 50 Fund ETF
Proporção0%
SPDR MSCI Emerging Markets Fossil Fuel Reserves Free ETF
Proporção0%
ProShares Ultra Nasdaq Biotechnology
Proporção0%
National Security Emerging Markets Index ETF
Proporção0%
Invesco Nasdaq Biotechnology ETF
Proporção0%
Xtrackers Emg Mkt Carbon Reduction and Cl Imp ETF
Proporção0%
DFA Dimensional Emerging Core Equity Market ETF
Proporção0%
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
Proporção0%
WisdomTree Emerging Markets Efficient Core Fund
Proporção0%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
